Literature DB >> 7791794

Characterization of promoter elements required for cell-specific expression of the neurotensin/neuromedin N gene in a human endocrine cell line.

B M Evers1, X Wang, Z Zhou, C M Townsend, G P McNeil, P R Dobner.   

Abstract

Expression of the gene encoding neurotensin/neuromedin N (NT/N) is mostly limited to the brain and specialized enteroendocrine cells (N cells) of the distal small intestine. We have analyzed the NT/N DNA sequences upstream of the RNA start site that direct cell-specific expression using a novel human endocrine cell line, BON, that resembles intestinal N cells in several important aspects, including NT/N precursor protein processing, ratios of different NT/N mRNA forms, and high levels of constitutive expression of the NT/N gene. Transient transfection assays with plasmids with progressive 5' deletions of the rat NT/N promoter identified the proximal 216 bp of 5' flanking sequences as essential for high-level constitutive NT/N expression in BON cells. In addition, a detailed mutational analysis defined multiple regions within the proximal 216 bp that contribute to cell-specific NT/N expression. These elements include a proximal cyclic AMP response element (CRE)/AP-1-like motif (TGACATCA) that binds c-Jun, JunD, CRE-binding (CREB), and ATF proteins, a near-consensus glucocorticoid response element, and a distal consensus AP-1 site that binds c-Fos, Fra-1, and JunD. In addition, elements contained within two 21-bp imperfect direct repeats play an important role in NT/N expression in BON cells and may bind novel factors that act as positive regulators of NT/N expression. DNase I footprinting and gel shift analyses demonstrate that the sites identified by mutational analysis, and at least one additional site, specifically bind BON cell nuclear proteins in vitro. We speculate that a complex pattern of regulation requiring interaction between a proximal CRE/AP-1-like motif and other upstream control elements play an important role in the high-level constitutive expression of NT/N in the human endocrine cell line BON. In addition, the BON cell line provides a unique model to further characterize the factors regulating cell-specific NT/N expression and to better understand the mechanisms responsible for the terminal differentiation of the N-cell lineage in the gut.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7791794      PMCID: PMC230627          DOI: 10.1128/MCB.15.7.3870

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  79 in total

1.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

2.  BON cells display the intestinal pattern of neurotensin/neuromedin N precursor processing.

Authors:  R E Carraway; S P Mitra; B M Evers; C M Townsend
Journal:  Regul Pept       Date:  1994-08-31

3.  c-fos antisense oligonucleotide specifically attenuates haloperidol-induced increases in neurotensin/neuromedin N mRNA expression in rat dorsal striatum.

Authors:  K M Merchant
Journal:  Mol Cell Neurosci       Date:  1994-08       Impact factor: 4.314

4.  Characterization of a human pancreatic carcinoid in vitro: morphology, amine and peptide storage, and secretion.

Authors:  D Parekh; J Ishizuka; C M Townsend; B Haber; R D Beauchamp; G Karp; S W Kim; S Rajaraman; G Greeley; J C Thompson
Journal:  Pancreas       Date:  1994-01       Impact factor: 3.327

5.  Temporal-specific and spatial-specific patterns of neurotensin gene expression in the small bowel.

Authors:  B M Evers; J A Ehrenfried; X Wang; C M Townsend; J C Thompson
Journal:  Am J Physiol       Date:  1994-11

6.  ATF-a0, a novel variant of the ATF/CREB transcription factor family, forms a dominant transcription inhibitor in ATF-a heterodimers.

Authors:  R Pescini; W Kaszubska; J Whelan; J F DeLamarter; R Hooft van Huijsduijnen
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

7.  Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D2 receptor antagonist.

Authors:  D J Sirinathsinghji; R Schuligoi; R P Heavens; A Dixon; S D Iversen; R G Hill
Journal:  Neuroscience       Date:  1994-09       Impact factor: 3.590

8.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

Authors:  L A Greene; A S Tischler
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

9.  Effect of aging on neurotensin-stimulated growth of rat small intestine.

Authors:  B M Evers; M Izukura; S Rajaraman; D Parekh; K Thakore; K Yoshinaga; T Uchida; C M Townsend; J C Thompson
Journal:  Am J Physiol       Date:  1994-08

10.  Enhanced expression of neurotensin/neuromedin N mRNA and products of NT/NMN precursor processing in neonatal rats.

Authors:  K Muraki; S P Mitra; P R Dobner; R E Carraway
Journal:  Peptides       Date:  1993 Nov-Dec       Impact factor: 3.750

View more
  9 in total

1.  Characterization of promoter elements regulating the expression of the human neurotensin/neuromedin N gene.

Authors:  Xiaofu Wang; Pat Gulhati; Jing Li; Paul R Dobner; Heidi Weiss; Courtney M Townsend; B Mark Evers
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

2.  Fetal and neoplastic expression of the neurotensin gene in the human colon.

Authors:  B M Evers; Z Zhou; V Dohlen; S Rajaraman; J C Thompson; C M Townsend
Journal:  Ann Surg       Date:  1996-05       Impact factor: 12.969

3.  Neurotensin phosphorylates GSK-3alpha/beta through the activation of PKC in human colon cancer cells.

Authors:  Qingding Wang; Yuning Zhou; B Mark Evers
Journal:  Neoplasia       Date:  2006-09       Impact factor: 5.715

4.  mTORC1 inhibition increases neurotensin secretion and gene expression through activation of the MEK/ERK/c-Jun pathway in the human endocrine cell line BON.

Authors:  Jing Li; Jianyu Liu; Jun Song; Xiaofu Wang; Heidi L Weiss; Courtney M Townsend; Tianyan Gao; B Mark Evers
Journal:  Am J Physiol Cell Physiol       Date:  2011-04-20       Impact factor: 4.249

5.  NFATc1 regulation of TRAIL expression in human intestinal cells.

Authors:  Qingding Wang; Yuning Zhou; Heidi L Weiss; Chi-Wing Chow; B Mark Evers
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

6.  DNA plasticity is a key determinant of the energetics of binding of Jun-Fos heterodimeric transcription factor to genetic variants of TGACGTCA motif.

Authors:  Kenneth L Seldeen; Caleb B McDonald; Brian J Deegan; Vikas Bhat; Amjad Farooq
Journal:  Biochemistry       Date:  2009-12-29       Impact factor: 3.162

7.  Characterization of early developmental pattern of expression of neurotensin/neuromedin N gene in foregut and midgut.

Authors:  X M Wang; B M Evers
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

8.  Evolution of motif variants and positional bias of the cyclic-AMP response element.

Authors:  Brandon Smith; Hung Fang; Youlian Pan; P Roy Walker; A Fazel Famili; Marianna Sikorska
Journal:  BMC Evol Biol       Date:  2007-02-08       Impact factor: 3.260

9.  Effect of Monoclonal Antibody Blockade of Long Fragment Neurotensin on Weight Loss, Behavior, and Metabolic Traits After High-Fat Diet Induced Obesity.

Authors:  Zherui Wu; Nicolas Stadler; Amazigh Abbaci; Jin Liu; Agnès Boullier; Nicolas Marie; Olivier Biondi; Marthe Moldes; Romain Morichon; Bruno Feve; Olle Melander; Patricia Forgez
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-08       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.